Abstract Treatment guidelines for binge eating disorder (BED) lack substantial recommendations for specific pharmacological management beyond lisdexamfetamine. This may lead clinicians to question what other options are available for managing BED. The following clinical scenarios will review existing data examining the use of several pharmacological agents for BED, including stimulants, glucagon-like peptide-1 agonists, naltrexone, antidepressants, and antiseizure medications.
Andrew M Williams (Mon,) studied this question.